NEUROONE MEDICAL TECHNOLOGIES CorpNMTC
Market cap
$35.8M
P/E ratio
| Dec 31, 2011 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | Sep 30, 2024 | |
| Product revenue | 6,963 | 773 | 742 | - | - | - | - | 178,146 | 171,169 | 2 | 3 |
| Cost of product revenue | 2,138 | - | - | - | - | - | - | 275,895 | 241,963 | 1 | 2 |
| Product gross profit | 4,825 | - | - | - | - | - | - | -97,749 | -70,794 | 456,517 | 1 |
| Collaborations revenue | - | - | - | - | - | - | 2 | 64,812 | 2 | 1 | - |
| Selling, general and administrative | - | - | - | - | - | - | - | - | 7 | 7 | 8 |
| Research and development | - | - | - | - | - | 2 | 2 | 4 | 5 | 7 | 5 |
| Total operating expenses | 41,076 | 36,687 | 49,587 | 32,611 | - | 6 | 7 | 10 | 12 | 14 | 13 |
| Loss from operations | - | -35,914 | -48,845 | -32,611 | - | -5,813,394 | -4,902,261 | -10,218,211 | -10,030,765 | -11,955,250 | -11,887,209 |
| Fair value change in warrant liability | - | - | - | - | - | - | - | - | - | - | 327,092 |
| Financing costs | - | - | - | - | - | - | - | - | - | - | 228,988 |
| Other income, net | - | - | - | - | - | - | - | - | - | 95,759 | 125,179 |
| Loss before income taxes | - | - | - | - | - | - | - | - | - | -11,859,491 | -12,318,110 |
| Provision for income taxes | - | - | - | - | - | - | - | -271,122 | - | - | - |
| Net loss | -27,604 | -36,244 | -62,863 | -47,775 | - | -6,781,161 | -13,640,160 | -9,948,168 | -9,999,613 | -11,859,491 | -12,318,110 |
| Basic (in Dollars per share) | - | - | - | - | - | - | - | - | -0.63 | -0.65 | -0.46 |
| Diluted (in Dollars per share) | - | - | - | - | - | - | - | - | -0.63 | -0.65 | -0.46 |